Analysis of surgical treatment results of patients with chronic rhinitis

Introduction. Chronic nasal congestion caused by edema of inferior turbinate affect 20% of population and strongly influences their quality of life. Pharmacological treatment of chronic rhinitis is considered to be the first line therapy. However, if conservative treatment is not effective and clinical signs are not disappearing the question about relevant surgical treatment is arising. Nowadays there are many methods of exposure on mucosa of the inferior turbinate. Considering high incidence of the pathology surgical treatment is of current importance in modern otorhinolaryngology.

Objective. Assessment of the effectiveness and comparison of the period of rehabilitation after submucosal laser destruction by laser beam with wavelength 1,56 and after submucosal destruction by radiosurgical instruments Ellman Surgitron with a frequency of 4 MHz in patients with chronic rhinitis.

Methods. 60 patients were included into the study aged from 18 to 80 years old with chronic rhinitis. All the patients were admitted to the department to perform surgical treatment. Semiconducted laser with wavelength 1,56 and radiosurgical instrument Ellman Surgitron with frequency of 4 MHz were applied to the treatment. We assessed SNOT20 score, endoscopic features, anterior active rhinomanometry and saccharin test results in all patients following the surgery.

Conclusions. The data we have obtained provide the basis for choosing semiconductor laser as more effective and safe technique for the treatment of patients with chronic rhinitis.

1. Bousquet J., Khaltaev N., Cruz A.A., Denburg J., Fokkens W.J., Togias A. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008. Allergy. 2008;63(S86):8–160. doi: 10.1111/j.1398-9995.2007.01620.x.

2. Seeger J., Zenev E., Gundlach P., Stein T., Müller G. Bipolar radiofrequency-induced thermotherapy of turbinate hypertrophy: pilot study and 20 months’ follow-up. Laryngoscope. 2003;113(1):130–135. doi: 10.1097/00005537-200301000-00024.

3. Sur D.K.C., Plesa M.L. Chronic Nonallergic Rhinitis. Am Fam Physician. 2018;98(3):171–176. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30215894.

4. Settipane R.A., Charnock D.R. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunology. 2007;19:23–34. Available at: https://www. ncbi.nlm.nih.gov/pubmed/17153005.

5. Akimov A.V. Clinical and functional justification of radio wave surgery of vaso­ motor rhinitis: autoref. dis. Cand. Med. Sci. Saint Petersburg; 2009. (In Russ.) Available at: http://medical-diss.com/docreader/287207/a?#?page=1.

6. Yanov Yu.K., Koshel’ V.I., Ivolga T.I., Koshel’ I.V. Regional aspects of the prevalence and organization of care for patients with chronic hypertrophic rhinitis in the Stavropol territory. Rossiyskaya otorinolaringologiya = Russian Otorhinolaryngology. 2010;(2):460–465. (In Russ.) Available at: https://elibrary.ru/item.asp?id=27627028.

7. Manesh P.A. Implementing precision medicine in best practices of chronic airway diseases. Indian J Med Res. 2019;149(6):802–803. doi: 10.4103/ijmr.IJMR_608_19.

8. Hellings P.W., Klimek L., Cingi C., Agache I., Akdis C., Bachert C. et al. Non‐allergic Rhinitis: Position Paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2017;72(11):1657–1665. doi: 10.1111/all.13200.

9. Settipane R.A., Kaliner M.A. Nonallergic rhinitis. Am J Rhinol Allergy. 2013;27(3S):S48–S51. doi: 10.2500/ajra.2013.27.3927.

10. Kaliner M.A. Nonallergic rhinopathy (formerly known as vasomotor rhinitis).Immunol Allergy Clin North Am. 2011;31(3):441–455. doi: 10.1016/j.iac.2011.05.007.

11. Meng C., Li L., Jiang X., Dong Z., Zhu D. Clinical characteristics in patients with non-allergic rhinitis and allergic rhinitis: preliminary analysis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010;45(12):999–1002. (In Chinese) Available at: https://www.ncbi.nlm.nih.gov/pubmed/21215048.

12. Segboer C.L., Holland C.T., Reinartz S.M., Terreehorst I., Gevorgyan A., Hellings P.W. et al. Nasal hyper‐reactivity is a common feature in both allergic and nonallergic rhinitis. Allergy. 2013;68(11):1427–1434. doi: 10.1111/all.12255.

13. Alt J.A., Sautter N.B., Mace J.C., Detwiller K.Y., Smith T.L. Antisomnogenic cytokines, quality of life, and chronic rhinosinusitis: a pilot study. Laryngoscope. 2014;124(4):E107–E114. doi: 10.1002/lary.24412.

14. Bernstein J.A. Nonallergic rhinitis: therapeutic options. Curr Opin Allergy Clin Immunol. 2013;13(4):410–416. doi: 10.1097/ACI.0b013e3283630cd8.

15. Kryukov A.I., Tsarapkin G.Yu., Zairat’yants O.V., Tovmasyan A.S., Panasov S.A., Artem’eva-Karelova A.V. The modern aspects of the surgical treatment of vasomotor rhinitis. Rossiyskaya Rinologiya = Russian Rhinology. 2017;25(2):10-14. (In Russ.) doi: 10.17116/rosrino201725210-14.

16. Lynde C.W., Sussman G., Dion P.L., Guenther L., Hébert J., Rao J. et al. Multidisciplinary Real-World Experience With Bilastine, a Second Generation Antihistamine. J Drugs Dermatol. 2020;19(2):145–154. doi: 10.36849/JDD.2020.4835.

17. Segboer C., Gevorgyan A., Avdeeva K., Chusakul S., Kanjanaumporn J., Aeumjaturapat S. et al. Intranasal corticosteroids for non-allergic rhinitis. Cochrane Database Syst Rev. 2019;2019(11). doi: 10.1002/14651858.CD010592.pub2.

18. Tan L., Xu Y. Application of nasal saline irrigation in nasal inflammatory diseases. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019;33(1):90–96. (In Chinese) doi: 10.13201/j.issn.1001-1781.2019.01.020

19. Kanjanawasee D., Seresirikachorn K., Chitsuthipakorn W., Snidvongs K. Hypertonic Saline Versus Isotonic Saline Nasal Irrigation: Systematic Review and Metaanalysis. Am J Rhinol Allergy. 2018;32(4):269–279. doi: 10.1177/1945892418773566.

20. Drobyshev V.A., Shpagina L.A., Karmanovskaya S.A., Zaitseva I.G. Innovative technology full volume lavage of the nasal cavity in the treatment of allergic and vasomotor rhinitis. Vestnik otorinolaringologii = Bulletin of Otorhino­ laryngology. 2018;83(5):59–64. (In Russ.) doi: 10.17116/otorino20188305159.

21. Bridgerman M.B. Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis. Integr Pharm Res Pract. 2017;6:109–119. doi: 10.2147/IPRP.S129544.

22. Van Gerven L., Boeckxstaens G., Jorissen M., Fokkens W., Hellings P.W. Short‐ time cold dry air exposure: A useful diagnostic tool for nasal hyperresponsiveness. Laryngoscope. 2012;122(12):2615–2620. doi: 10.1002/lary.23495.

23. Hur K., Liang J., Lin S.Y. The role of secondhand smoke in sinusitis: a systematic review. Int Forum Allergy Rhinol. 2014;4(1):22–28. doi: 10.1002/alr.21232.

24. Ronmark E.P., Ekerljung L., Mincheva R., Sjolander S., Hagstad S., Wennergren G. et al. Different risk factor patterns for adult asthma, rhinitis and eczema: results from West Sweden Asthma Study. Clin Transl Allergy. 2016;6:28. doi: 10.1186/s13601-016-0112-0.

25. Hisinger-Mölkänen H., Piirilä P., Haahtela T., Sovijärvi A., Pallasaho P. Smoking, environmental tobacco smoke and occupational irritants increase the risk of chronic rhinitis. World Allergy Organization Journal. 2018;11:6. doi: 10.1186/s40413-018-0184-5.

26. Bhandarkar N.D., Smith T.L. Outcomes of surgery for inferior turbinate hypertrophy. Curr Opin Otolaryngol Head Neck Surg. 2010;18(1):49–53. doi: 10.1097/MOO.0b013e328334d974.

27. Passali D., Loglisci M., Politi L., Passali G.C., Kern E. Managing turbinate hypertrophy: coblation vs. radiofrequency treatment. Eur Arch Otorhinolaryngol. 2016;273:1449–1453. doi: 10.1007/s00405-015-3759-6.

28. Puterman M.M., Segal N., Joshua B.-Z. Endoscopic, assisted, modified turbinoplasty with mucosal flap. J Laryngol Otol. 2012;126(5):525–528. doi: 10.1017/S0022215112000163.

29. Tovar S.V., Delgadillo V. H. Immunotherapy as a Treatment for Patients With Allergic Rhinitis. Rev Alerg Mex. 1997;44(2):39–41. (In Spain) Available at: https://www.ncbi.nlm.nih.gov/pubmed/9296823.

30. Hartley C., Willatt D.J. Cryotherapy in the treatment in chronic nasal obstruction: indications in adults. J. Laryngol. Otol. 1995;109(8):729–732. doi: 10.1017/s0022215100131160.